TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ORIC

Oric Pharmaceuticals Inc

Healthcare · Biotechnology

13.20$ -0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Oric Pharmaceuticals Inc (ORIC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 405 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORIC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
274 255 351 329 302 274 243 347 431 411 437 405
232 213 324 295 279 262 211 291 296 288 290 274
26 23 56 50 44 59 49 76 50 46 56 37
227 208 317 286 272 256 204 283 287 281 282 265
27 31 22 27 28 31 23 23 24 27 21 23
19 20 15 20 21 25 18 18 20 20 18 21
2.7 2.8 2.8 2.8 3.1 3.2 3.2 3.3 3.3 3.3 3.3 3.3
3.7 0.9 3.0 2.3 4.2 1.5 5.2 3.1 2.9 3.8 2.9 3.9
247 224 329 302 274 243 220 324 407 384 416 381
-407 -435 -460 -492 -526 -563 -593 -629 -662 -692 -728 -770
57 57 67 70 71 71 71 78 99 88 105 108

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?